AION Healthspan is advancing a pipeline of cell therapies designed to slow or reverse biological decline in chronic disease, focusing on regenerative medicine and immunomodulation.
We are committed to building meaningful scientific relationships that can deepen our understanding of disease biology, validate our platform, and accelerate clinical translation.
We welcome collaboration opportunities with academic researchers, clinical investigators, and institutions to:
- Participate in clinical research and investigator-initiated trials
- Explore Expanded Access IND opportunities for patients with high unmet need
- Integrate our platform technologies into translational programs
If you’re interested in exploring a scientific collaboration with AION, please contact us at: info@aionhealthspan.com
Please inquire if you are an Investigator interested in partnering. AION Healthspan, Inc. has an established indirect cost rate at 30% of direct costs for all of our industry-sponsored research grants to Academic Institutions.